Chargement en cours...
Rivastigmine for Alzheimer's disease
BACKGROUND: Alzheimer's disease is the commonest cause of dementia affecting older people. One of the therapeutic strategies aimed at ameliorating the clinical manifestations of Alzheimer's disease is to enhance cholinergic neurotransmission in the brain by the use of cholinesterase inhibi...
Enregistré dans:
| Publié dans: | Cochrane Database Syst Rev |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley & Sons, Ltd
2015
|
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7050299/ https://ncbi.nlm.nih.gov/pubmed/26393402 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD001191.pub4 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|